{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:54:16Z","timestamp":1773712456043,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,20]]},"DOI":"10.4103\/0366-6999.187848","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T10:05:47Z","timestamp":1470650747000},"page":"1894-1903","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy"],"prefix":"10.1097","volume":"129","author":[{"given":"Jie","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-De","family":"Lun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Sheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210129","first-page":"709","article-title":"The commonest glomerulonephritis in the world: IgA nephropathy","volume":"64","author":"D\u2019Amico","year":"1987","journal-title":"Q J Med"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1523-1755.2004.00837.x","article-title":"Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio","year":"2002","journal-title":"N Engl J Med"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","article-title":"Remission of proteinuria improves prognosis in IgA nephropathy","volume":"18","author":"Reich","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-pathol-011110-130216","article-title":"IgA nephropathy: Molecular mechanisms of the disease","volume":"8","author":"Mestecky","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(74)90810-1","article-title":"Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis","volume":"2","author":"Brown","year":"1974","journal-title":"Lancet"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/oxfordjournals.ndt.a027280","article-title":"Effects of defibrotide treatment in patients with IgA nephropathy and reduced renal function","volume":"11","author":"Frasc\u00e0","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R9-2-20210129","first-page":"167","article-title":"Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function","volume":"3","author":"Savage","year":"1982","journal-title":"Int J Pediatr Nephrol"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(77)80554-4","article-title":"Severe glomerulonephritis complicated by coagulopathy: Treatment with anticoaguland and immunosuppresive drugs","volume":"90","author":"Robson","year":"1977","journal-title":"J Pediatr"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: Reading between the (guide) lines \u2013Application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"key":"R12-2-20210129","first-page":"1","article-title":"Glomerular score as a prognosticator in IgA nephropathy: Its usefulness and limitation","volume":"49","author":"Katafuchi","year":"1998","journal-title":"Clin Nephrol"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/ki.2010.462","article-title":"Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities","volume":"79","author":"Stevens","year":"2011","journal-title":"Kidney Int"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: A cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000225563","article-title":"Immunoglobulin A nephropathy in China: Progress and challenges","volume":"30","author":"Cai","year":"2009","journal-title":"Am J Nephrol"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"e91756","DOI":"10.1371\/journal.pone.0091756","article-title":"Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan","volume":"9","author":"Moriyama","year":"2014","journal-title":"PLoS One"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000197116","article-title":"Recent therapeutic strategies improve renal outcome in patients with IgA nephropathy","volume":"30","author":"Komatsu","year":"2009","journal-title":"Am J Nephrol"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","article-title":"Long-term renal survival and related risk factors in patients with IgA nephropathy: Results from a cohort of 1155 cases in a Chinese adult population","volume":"27","author":"Le","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0272-6386(12)80284-8","article-title":"Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses","volume":"18","author":"Alamartine","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2010010117","article-title":"Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy","volume":"21","author":"Pozzi","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N Engl J Med"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1681\/ASN.V131142","article-title":"Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy","volume":"13","author":"Ballardie","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.kjms.2014.04.002","article-title":"Cyclosporine A combined with medium\/low dose prednisone in progressive IgA nephropathy","volume":"30","author":"Xu","year":"2014","journal-title":"Kaohsiung J Med Sci"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2169\/internalmedicine.53.1136","article-title":"Comparison of glucocorticoids alone and combined with cyclosporine a in patients with IgA nephropathy: A prospective randomized controlled trial","volume":"53","author":"Liu","year":"2014","journal-title":"Intern Med"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2215\/CJN.01120905","article-title":"Steroid treatment for severe childhood IgA nephropathy: A randomized, controlled trial","volume":"1","author":"Yoshikawa","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ki.2009.499","article-title":"Long-term study of mycophenolate mofetil treatment in IgA nephropathy","volume":"77","author":"Tang","year":"2010","journal-title":"Kidney Int"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1523-1755.2005.00460.x","article-title":"Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/ndt\/gfh974","article-title":"Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: A double-blind randomized controlled trial","volume":"20","author":"Frisch","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"R30-2-20210129","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00296-009-0861-3","article-title":"The efficacy and safety of leflunomide therapy in lupus nephritis by repeat kidney biopsy","volume":"29","author":"Zhang","year":"2009","journal-title":"Rheumatol Int"},{"key":"R31-2-20210129","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1191\/096120301678416033","article-title":"Benefits of leflunomide in systemic lupus erythematosus: A pilot observational study","volume":"10","author":"Remer","year":"2001","journal-title":"Lupus"},{"key":"R32-2-20210129","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/nep.12143","article-title":"Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: A retrospective clinical study of efficacy and safety","volume":"18","author":"Yang","year":"2013","journal-title":"Nephrology (Carlton"},{"key":"R33-2-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1440-1797.2006.00547.x","article-title":"Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy","volume":"11","author":"Lou","year":"2006","journal-title":"Nephrology (Carlton"},{"key":"R34-2-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nep.12359","article-title":"Valsartan combined with clopidogrel and\/or leflunomide for the treatment of progressive immunoglobulin A nephropathy","volume":"20","author":"Cheng","year":"2015","journal-title":"Nephrology (Carlton"},{"key":"R35-2-20210129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/imt.10.52","article-title":"Leflunomide: A drug with a potential beyond rheumatology","volume":"2","author":"Teschner","year":"2010","journal-title":"Immunotherapy"},{"key":"R36-2-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: Mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"R37-2-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.rhu.0000081470.31167.8b","article-title":"Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis","volume":"9","author":"Perez-Ruiz","year":"2003","journal-title":"J Clin Rheumatol"},{"key":"R38-2-20210129","doi-asserted-by":"crossref","first-page":"e100801","DOI":"10.1371\/journal.pone.0100801","article-title":"Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: A meta-analysis of 15 cohort studies","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"R39-2-20210129","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/BOR.0000000000000033","article-title":"Serum uric acid and the risk of hypertension and chronic kidney disease","volume":"26","author":"Feig","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R40-2-20210129","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2169\/internalmedicine.50.5971","article-title":"Antithrombotic drug therapy for IgA nephropathy: A meta analysis of randomized controlled trials","volume":"50","author":"Liu","year":"2011","journal-title":"Intern Med"},{"key":"R41-2-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10157-006-0433-8","article-title":"Meta-analysis of antiplatelet therapy for IgA nephropathy","volume":"10","author":"Taji","year":"2006","journal-title":"Clin Exp Nephrol"},{"key":"R42-2-20210129","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/ndt\/gfh069","article-title":"Effects of co-administration of urokinase and benazepril on severe IgA nephropathy","volume":"19","author":"Chen","year":"2004","journal-title":"Nephrol Dial Transplant"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.187848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T10:53:08Z","timestamp":1657018388000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201608200-00002"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":41,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.187848","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,20]]}}}